MedPath

Effect of Oral Preparation on Bacterial Colonization of the Pharyngeal Mucosa in Surgery of Head and Neck Cancer

Phase 3
Completed
Conditions
Bacterial Infection
Interventions
Device: NaCl 0.9 %
Registration Number
NCT02753387
Lead Sponsor
Rennes University Hospital
Brief Summary

Surgical site infections are an important health indicator for hospitals and a significant medico-economic issue.

The aim of the study is to assess the impact of chlorhexidine mouthwash performed before surgery on the bacterial colonization of the pharyngeal mucosa.

Detailed Description

The main objective is to reduce the number of patients with significant pathogenic bacterial colonization for pharyngeal mucosa at the end of the surgery. Oral flora is the same as the pharyngeal flora, so this suggests that the action of the oral mouthwash may also act in pharyngeal mucosa by buccopharyngeal communication.

Patients will be randomized into two groups :

* preoperative oral preparation with sodium chloride (NaCl) 0.9% (control group)

* preoperative oral preparation with chlorhexidine (experimental group)

A quantitative and qualitative analysis will be performed from samples collected during the surgery : before mouthwash (T0), after mouthwash (T1), before intubation in the operating room (T2), after intubation (T3), before incision (T4) and just before the end of the intervention on the mucosal scar (T5)

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
80
Inclusion Criteria
  • Histological evidence of cancer regardless of histological type
  • Surgical treatment requiring mucosal effraction regardless of the surgical approach;
  • Patient over 18 years old;
  • Oral cancer, oropharyngeal cancer, hypopharyngeal cancer or laryngeal cancer;
  • Written and informed patient consent
Exclusion Criteria
  • Concomitant Vascular Interventions;
  • Interventional radiology;
  • Needing of second surgery at a same location during the 30 postoperative days);
  • Cancer of the paranasal sinus, nasal cavity, skull base, salivary glands, skin,
  • Neck dissection without mucosal effraction
  • Thyroid or parathyroid surgery
  • Size tumor forbidden tumor surgery
  • Allergy to any tested product;
  • Concurrent infection the day before or day of surgery
  • Protected adults (guardianship) and persons deprived of liberty

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
NaCl 0.9 %NaCl 0.9 %Patients will receive 1 preoperative oral preparation and 1 peroperative oral preparation of NaCl 0.9%
CHLORHEXIDINEChlorhexidinePatients will receive 1 preoperative oral preparation and 1 peroperative oral preparation of chlorhexidine
Primary Outcome Measures
NameTimeMethod
Percentage of patients with pharyngeal mucosa colonization (>=10^2 Colony Forming Unit (CFU)/ml of pathogen germs of the oral flora) at the end of the surgeryThe day of the surgery

The percentage of patients with pharyngeal mucosa colonization will be determined from the sample collected on the mucosal scar just before the end of the surgery (T5)

Secondary Outcome Measures
NameTimeMethod
Type of oral germsThe day of the surgery

The type of germs will be determined for all the samples collected during the surgery (i.e. before mouthwash (T0), after mouthwash (T1), before intubation in the operating room (T2), after intubation (T3), before incision (T4) and just before the end of the intervention on the mucosal scar (T5))

Number of positive cultures of pathogen germsThe day of the surgery

The number of positive cultures of pathogen germs will be determined for all the samples collected during the surgery (i.e. before mouthwash (T0), after mouthwash (T1), before intubation in the operating room (T2), after intubation (T3), before incision (T4) and just before the end of the intervention on the mucosal scar (T5))

Kinetics of the number of CFU/mlThe day of the surgery

The kinetics of the number of CFU/ml will be determined from all the samples collected during the surgery (i.e. before mouthwash (T0), after mouthwash (T1), before intubation in the operating room (T2), after intubation (T3), before incision (T4) and just before the end of the intervention on the mucosal scar (T5))

Change in the number of CFU/ml of pathogen germs before and after intubation (T2-T3)The day of the surgery

The change in the number of CFU/ml of pathogen germs will be assessed using the samples collected before (T2) and after intubation (T3)

Number of patients with a significant rate of pathogen germs (>=10^2 CFU/ml) at T1The day of the surgery

The number of patients with a significant rate of pathogen germs will be determined from the sample collected after mouthwash (T1)

Number of CFU/ml of pathogens germsThe day of the surgery

The number of CFU/ml of pathogens germs will be determined for all the samples collected during the surgery (i.e. before mouthwash (T0), after mouthwash (T1), before intubation in the operating room (T2), after intubation (T3), before incision (T4) and just before the end of the intervention on the mucosal scar (T5))

Surgical site infections rate in the postoperative month (standard definition of the Centers for Disease Control and Prevention, Atlanta)30 days
Number of patients who processed correctly preoperative mouthwashThe day of the surgery

Trial Locations

Locations (1)

Rennes University Hospital

🇫🇷

Rennes, France

© Copyright 2025. All Rights Reserved by MedPath